Omacor and Placebo in Carotid Plaque Stability - No Study Results Posted - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Omacor and Placebo in Carotid Plaque Stability

This study has been completed.

Study NCT00294216 Information provided by Pronova BioPharma

First Received: February 17, 2006 No Changes Posted

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	July 2005
Estimated Primary Completion Date:	No date given

No publications provided by Pronova BioPharma

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Cawood AL, Ding R, Napper FL, Young RH, Williams JA, Ward MJ, Gudmundsen O, Vige R, Payne SP, Ye S, Shearman CP, Gallagher PJ, Grimble RF, Calder PC. Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. Atherosclerosis. 2010 Sep;212(1):252-9. Epub 2010 May 20.

Back to top of Main Content